Cyclo Therapeutics Inc (CYTH)
0.7212
0.00 (0.00%)
USD |
NASDAQ |
Nov 08, 14:08
Cyclo Therapeutics Revenue (TTM): 1.132M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.132M |
| March 31, 2024 | 1.126M |
| December 31, 2023 | 1.076M |
| September 30, 2023 | 0.9518M |
| June 30, 2023 | 0.9085M |
| March 31, 2023 | 1.333M |
| December 31, 2022 | 1.376M |
| September 30, 2022 | 1.774M |
| June 30, 2022 | 1.726M |
| March 31, 2022 | 1.422M |
| December 31, 2021 | 1.586M |
| September 30, 2021 | 1.146M |
| June 30, 2021 | 0.9648M |
| March 31, 2021 | 0.9358M |
| December 31, 2020 | 0.9034M |
| September 30, 2020 | 0.9852M |
| June 30, 2020 | 1.049M |
| March 31, 2020 | 1.112M |
| December 31, 2019 | 1.007M |
| September 30, 2019 | 1.019M |
| June 30, 2019 | 0.9579M |
| March 31, 2019 | 1.034M |
| December 31, 2018 | 1.012M |
| September 30, 2018 | 0.9404M |
| June 30, 2018 | 0.9571M |
| Date | Value |
|---|---|
| March 31, 2018 | 1.131M |
| December 31, 2017 | 1.238M |
| September 30, 2017 | 1.597M |
| June 30, 2017 | 1.634M |
| March 31, 2017 | 1.495M |
| December 31, 2016 | 1.503M |
| September 30, 2016 | 1.138M |
| June 30, 2016 | 1.094M |
| March 31, 2016 | 1.090M |
| December 31, 2015 | 0.9505M |
| September 30, 2015 | 1.234M |
| June 30, 2015 | 1.387M |
| March 31, 2015 | 1.180M |
| December 31, 2014 | 1.567M |
| September 30, 2014 | 1.356M |
| June 30, 2014 | 1.135M |
| March 31, 2014 | 1.670M |
| December 31, 2013 | 1.693M |
| September 30, 2013 | 1.757M |
| June 30, 2013 | 1.747M |
| March 31, 2013 | 1.186M |
| December 31, 2012 | 1.045M |
| September 30, 2012 | 0.9244M |
| June 30, 2012 | 0.9982M |
| March 31, 2012 | 1.219M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.9034M
Minimum
Dec 2020
1.774M
Maximum
Sep 2022
1.185M
Average
1.112M
Median
Mar 2020
Revenue (TTM) Benchmarks
| Stryker Corp | 21.97B |
| Biogen Inc | 9.608B |
| Pfizer Inc | 59.37B |
| Pacira BioSciences Inc | 694.96M |
| Moderna Inc | 4.988B |